References
- Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases. Rev Rhum Mal Osteoartic.. 1987;54:187–196.
- Kahn MF, Khan MA. The SAPHO syndrome. Baillieres Clin Rheumatol.. 1994;8:333–362.
- Vittecoq O, Said LA, Michot C, Mejjad O, Thomine JM, Mitrofanoff P, et al. Evolution of chronic multifocal osteitis toward spondyloarthropathy over the long term. Arthritis Rheum.. 2000;43:109–119.
- Hayem G, Bouchaud-Chabot A, Benali K, Roux S, Palazzo E, Silbermann-Hoffman O, et al. SAPHO syndrome: a long-term follow-up of 120 cases. Semin Arthritis Rheum.. 1999;29:159–171.
- Rohekar G, Inman RD. Conundrums in nosology: synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome and spondylarthritis. Arthritis Rheum.. 2006;55:665–669.
- Hurtado-Nedelec M, Cholett-Martin S, Nicaise-Roland P, Grootenboer-Mignot S, Ruimy R, Meyer O, et al. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology (Oxford). 2008;47:1160–1167.
- Rozin AP. SAPHO syndrome: is a range of pathogen-associated rheumatic diseases extended?. Arthritis Res Ther.. 2009;11:131
- Assmann G, Kueck O, Kirchhoff T, Rosenthal H, Voswinkel J, Pfreundschuh M, et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthitis Res Ther.. 2009;11:R140
- Colina M, Lo Monaco A, Khodeir M, Trotta F. Propionibacterium acnes and SAPHO syndrome: a case report and literature review. Clin Exp Rheumatol.. 2007;25:457–460.
- Kalke S, Perera SD, Patel ND, Gordon TE, Dasgupta B. The sternoclavicular syndrome: experience from a district general hospital and results of a national postal survey. Rheumatology. 2001;40:170–177.
- Jansson A, Renner ED, Ramser J, Mayer A, Haban M, Meindl A, et al. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford). 2007;46:154–160.
- Ferguson PJ, Sandu M. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep.. 2012;14:130–141.
- Takigawa T, Tanaka M, Nakanishi K, Misawa H, Sugimoto Y, Takahata T, et al. SAPHO syndrome associated spondylitis. Eur Spine J.. 2008;17:1391–1397.
- Schaeverbeke T, Lequen L, Barbeyrac B, Labbé L, Bébéar CM, Morrier Y, et al. Propionibacterium acnes isolated from synovial tissue and fluid in a patient with oligoarthritis associated with acne and pustulosis. Arthritis Rheum.. 1998;41:1889–1893.
- Ballara SC, Siraj QH, Maini RN, Venables PJ. Sustained response to doxycycline therapy in two patients with SAPHO syndrome. Arthritis Rheum.. 1999;42:819–821.
- Perry A, Lambert P. Propionibacterium acnes: infection beyond the skin. Expert Rev Anti Infect Ther. 2011;9:1149–1156.
- Colina M, Govoni M, Orzincolo C, Trotta F. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum.. 2009;61:813–821.
- Griffin MO, Ceballos G, Villarreal FJ. Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action. Pharm Res.. 2011;63:102–107.
- Pang T, Wang J, Benicky J, Saavedra JM. Minocycline ameliorates LPS-induced inflammation in human monocytes by novel mechanisms including LOX-1, Nur77 and LITAF inhibition. Biochim Biophys Acta.. 2012;1820:503–510.
- Zhao Z, Li Y, Li Y, Zhao H, Li H. Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with review of the relevant published work. J Dermatol.. 2011;38:155–159.